Product information
From Health Canada
Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.
Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.
Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.
- Natural Product Number (NPN):
- 80038376
- Market status:
- Marketed
- Licence Status:
- Active
- Brand name(s):
- Joint Pain Relief
- Licence holder:
- New Roots Herbal Inc.
- Dosage Form:
- Capsule
- Recommended route of administration:
-
Oral
Sub population (Sub Pop.) | Quantity (Qty) | Frequency (Freq.) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sub Pop. | Age | Min. | Max. | UoM Footnote1 Age | Qty | Min. | Max. | UoM Qty | Freq. | Min. | Max. | UoM Freq. |
Adults | 1.0 | capsule | 2 | daily | ||||||||
- Recommended use or purpose:
- NEM¿ Helps provide relief from joint pain due to moderate intensity aerobic exercise (as quickly as 1 day). NEM¿ is Clinically proven to provide relief from joint stiffness due to moderate intensity aerobic exercise (in as little as 5 days). NEM® increases joint flexibility. NEM® helps reduce joint pain and stiffness. NEM® helps to relieve joint pain and stiffness associated with osteoarthritis (of the knee). NEM® helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise in post-menopausal women NEM® helps to minimize discomfort due to moderate intensity aerobic exercise in post-menopausal women. NEM® helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation due to moderate intensity aerobic exercise in post-menopausal women. NEM® helps reduce levels of CTX-II, a biomarker/marker of joint degradation due to moderate intensity aerobic exercise in post-menopausal women.
- Helps to relieve joint pain associated with osteoarthritis. Provides antioxidants for the maintenance of good health.
- Risk Information:
- Cautions and Warnings
- Consult a health care practitioner prior to use if you are allergic to eggs. Consult a health care practitioner if symptoms persist and/or worsen. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are taking antiplatelet medication or blood thinners. Consult a health care practitioner prior to use if you have gallstones or a bile duct obstruction. Consult a health care practitioner prior to use if you have stomach ulcers or excess stomach acid. Hypersensitivity (e.g. allergy) has been known to occur, in which case, discontinue use. Consult a health care practitioner prior to use if you are taking any other medications or natural health products.
Medicinal ingredients | Quantity (Qty) | Extract | Potency |
---|---|---|---|
(1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione |
100.0 mg
|
||
Boswellia serrata |
150.0 mg
|
35.0
%
Boswellic Acid 70.0 % Organic Acids |
|
Harpagophytum procumbens |
150.0 mg
|
10
:
1
DHE: 1500 mg |
5.0
%
Harpagosides |
Partially hydrolysed chicken eggshell membrane |
250.0 mg
|
||
Piper nigrum |
2.0 mg
|
95.0
%
Piperine |
- List of non-medicinal ingredients:
-
- Hypromellose
- Magnesium Stearate
- Purified water
- Date of licensing:
- 2012-12-19
- Revised date of licence:
- 2023-07-17
Application information
Related information
Contact us
For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).